Cite
HARVARD Citation
Yan, F. et al. (n.d.). 101P Safety and effectiveness of pembrolizumab combined with albumin-bound paclitaxel and nedaplatin as first-line treatment in advanced esophageal squamous cell carcinoma patients. Immuno-oncology technology. p. . [Online].